Lavinia M Proctor Selected Research

AcPhe(ornithine- Pro- cyclohexylamine- Trp- Arg)

1/2006	Transdermal pharmacology of small molecule cyclic C5a antagonists.
8/2005	Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lavinia M Proctor Research Topics

Disease

4	Reperfusion Injury 12/2006 - 09/2003
3	Wounds and Injuries (Trauma) 12/2006 - 09/2003
3	Neutropenia 08/2006 - 09/2003
1	Hemorrhagic Shock 08/2006
1	Burns 08/2006
1	Shock 08/2006
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 08/2006
1	Sepsis (Septicemia) 08/2006
1	Lung Injury 08/2006
1	Huntington Disease (Huntington's Disease) 07/2006
1	Inflammation (Inflammations) 01/2006
1	Body Weight (Weight, Body) 08/2005
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2005
1	Colitis 08/2005
1	Edema (Dropsy) 08/2005
1	Hypotension (Low Blood Pressure) 09/2003

Drug/Important Bio-Agent (IBA)

5	Complement System Proteins (Complement)IBA 12/2006 - 06/2004
3	Anaphylatoxin C5a ReceptorIBA 07/2006 - 06/2004
2	hydrocinnamate- cyclo(ornithyl- prolyl- cyclohexylalanyl- tryptophyl- arginyl)IBA 07/2006 - 08/2005
2	AcPhe(ornithine- Pro- cyclohexylamine- Trp- Arg)IBA 01/2006 - 08/2005
1	cobra venom factorIBA 08/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2006
1	3-nitropropionic acidIBA 07/2006
1	Cyclic PeptidesIBA 01/2006
1	Factor VaIBA 08/2005
1	Sulfonic AcidsIBA 08/2005
1	Pharmaceutical PreparationsIBA 08/2005
1	Dihydrotachysterol (AT 10)IBA 08/2005
1	sym-trinitrobenzeneIBA 08/2005
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2003
1	Leukotriene C4IBA 09/2003
1	Celecoxib (Celebrex)FDA Link 09/2003
1	zafirlukast (Accolate)FDA LinkGeneric 09/2003
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2003
1	Secretory Phospholipases A2IBA 09/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2006
1	Intravenous Infusions 08/2006
1	Controlled Hypotension 01/2006
1	Topical Administration 01/2006
1	Oral Administration 01/2006